Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02326467Phase 1Completed
Phase 1, open-label, single-arm trial of chlorhexidine in Healthcare-associated infection (HAI). Primary endpoint: Percentage of Study Participants With Skin Reactions Less Than 10%. Started Feb 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02326467.